Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
Main Authors: | Javier Egea, Francisco López-Muñoz, Oscar Fernández-Capetillo, Russel J. Reiter, Alejandro Romero |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.873197/full |
Similar Items
-
Editorial: Therapeutic Advances in Melatonin Research
by: Francisco López-Muñoz, et al.
Published: (2022-06-01) -
Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
by: Eva Ramos, et al.
Published: (2023-05-01) -
Epoxidation reactions of natural limonene, piperine and piperic acid, as intercalative alkylating agents for DNA/
by: 497124 Elgendy, E. M. -
Melatonin and Nitrones As Potential Therapeutic Agents for Stroke
by: Alejandro Romero, et al.
Published: (2016-11-01) -
Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics
by: Ana Capote-Moreno, et al.
Published: (2019-11-01)